FIELD: medicine, leprology. SUBSTANCE: laboratory CBA line mice are intragastrally introduced with diaphenylsulfone at the dosage of 12.5 mg/kg body weight in combination with muramyldipeptide heptylglycoside at the dosage of 150- 50 mg/kg body weight for 8 weeks. EFFECT: higher efficiency of therapy. 5 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MODELING LEPROSY | 1993 |
|
RU2098866C1 |
METHOD OF LEPROUS INFECTION MODELLING | 1995 |
|
RU2102482C1 |
METHOD FOR TREATING EXPERIMENTAL LEPROUS INFECTION | 2006 |
|
RU2322991C1 |
METHOD OF IMMUNOPROPHYLAXIS OF EXPERIMENTAL LEPROSY INFECTION | 1996 |
|
RU2135196C1 |
METHOD OF TREATING EXPERIMENTAL LEPROUS INFECTION | 2011 |
|
RU2467742C1 |
METHOD FOR EVALUATING EFFICIENCY OF ANTILEPROUS MEDICINAL PREPARATIONS | 2003 |
|
RU2242761C1 |
METHOD OF LEPROSY DIAGNOSIS | 1996 |
|
RU2124730C1 |
METHOD OF OBTAINING EXTRACT POSSESSING ANTI-LEPROSY ACTIVITY | 2009 |
|
RU2410111C1 |
METHOD OF SIMULATING MACROPHAGE DEFECT | 1994 |
|
RU2105352C1 |
METHOD OF ESTIMATION OF LEPROSY RELAPSE RISK GROUP | 1993 |
|
RU2082979C1 |
Authors
Dates
2002-08-27—Published
1999-07-27—Filed